Dr. Adam Richard Kawinski, MD

Dr. Kawinski practices at Sisters of Charity Hospital in Buffalo, New York, part of Catholic Health System.

Dr. Kawinski's NPI, 1609294917, was assigned on April 3, 2014. Dr. Kawinski holds New York license 292235.

Dr. Kawinski's primary practice is Sisters of Charity Hospital, at 2157 Main Street, Buffalo, NY 14214 in Erie County. The practice phone is (716) 862-1000.

Dr. Kawinski's primary practice is Sisters of Charity Hospital in Buffalo, New York, part of Catholic Health System. The medical group on file is Associated Physicians of Western New York, P.C. Dmand AI also links Dr. Kawinski to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kawinski practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Kawinski's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Kawinski is licensed in New York.

CMS data shows 410 Medicare services from Dr. Kawinski across 4 procedure codes in 2024, for 177 Medicare patients. Medicare paid $22,706 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 177 Medicare patients who saw Dr. Kawinski in 2024. The largest group is 75 to 84, with 57 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 47% are also on Medicaid. Their average risk score is 3.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kawinski's median patient age at 65, with 54% women.

In 2024, Dr. Kawinski wrote 138 Medicare Part D claims for 72 patients. 83% of them were for generic drugs. CMS names the drug for 37 of them, across 3 drugs with 11 or more claims each, at $321 in total drug cost. In 2023, CMS named 41 claims across 3 drugs.

Dr. Kawinski accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 23 general payments to Dr. Kawinski from 8 drug and device companies from 2021 to 2024. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $162.